Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Font

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
Medicine|October 8, 2003
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patientsRicard Cervera, Munther A Khamashta, Josep Font, et al.
Arthritis and Rheumatism|December 14, 2004
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis TrialFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Arthritis and Rheumatism|September 5, 2002
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamideFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Arthritis Care & Research|January 29, 2014
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohortApinya Lertratanakul, Peggy Wu, Alan Dyer, et al.
Arthritis and Rheumatism|April 16, 2002
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsRicard Cervera, Jean-Charles Piette, Josep Font, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
Medicine|October 8, 2003
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patientsRicard Cervera, Munther A Khamashta, Josep Font, et al.
Arthritis and Rheumatism|December 14, 2004
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis TrialFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Arthritis and Rheumatism|September 5, 2002
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamideFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Arthritis Care & Research|January 29, 2014
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohortApinya Lertratanakul, Peggy Wu, Alan Dyer, et al.
Arthritis and Rheumatism|April 16, 2002
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsRicard Cervera, Jean-Charles Piette, Josep Font, et al.
Pageof 16